Horizon Kinetics Medical ETF MEDX

Medalist Rating as of | See Horizon Kinetics Investment Hub

Morningstar’s Analysis MEDX

Will MEDX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Horizon Kinetics Medical ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MEDX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 68.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

19.62 3M
Healthcare

AbbVie Inc

10.02 2M
Healthcare

US BANK MMDA - USBGFS 7

7.89 1M
Cash and Equivalents

Novartis AG ADR

6.86 1M
Healthcare

Johnson & Johnson

5.89 1M
Healthcare

Amgen Inc

4.81 834,979
Healthcare

Alkermes PLC

4.65 806,535
Healthcare

AstraZeneca PLC

4.45 770,973
Healthcare

Merck & Co Inc

4.34 752,781
Healthcare

Bristol-Myers Squibb Co

4.24 734,661
Healthcare

Sponsor Center